Search Results - "Keipert, Peter E."
-
1
An Overview of Two Human Trials of Perfluorocarbon Emulsions in Noncardiac Surgery
Published in Shock (Augusta, Ga.) (01-10-2019)Get full text
Journal Article -
2
Clinical Evaluation of MP4CO: A Phase 1b Escalating-Dose, Safety and Tolerability Study in Stable Adult Patients with Sickle Cell Disease
Published in Advances in experimental medicine and biology (2016)“…MP4CO, developed by Sangart Inc. (San Diego, CA), is a pegylated human hemoglobin-based carbon monoxide (CO) delivery agent and oxygen therapeutic that has…”
Get more information
Journal Article -
3
Evaluation of MP4OX for prevention of perioperative hypotension in patients undergoing primary hip arthroplasty with spinal anesthesia: a randomized, double-blind, multicenter study
Published in Anesthesiology (Philadelphia) (01-05-2011)“…MP4OX (oxygenated polyethylene glycol-modified hemoglobin) is an oxygen therapeutic agent with potential applications in clinical settings where targeted…”
Get full text
Journal Article -
4
A Double-Blind, Randomized, Multicenter Study of MP4OX for Treatment of Perioperative Hypotension in Patients Undergoing Primary Hip Arthroplasty Under Spinal Anesthesia
Published in Anesthesia and analgesia (01-04-2011)“…MP4OX (oxygenated polyethylene glycol-modified hemoglobin) is a novel oxygen therapeutic agent specifically developed to perfuse and oxygenate tissue at risk…”
Get full text
Journal Article -
5
Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
Published in JAMA : the journal of the American Medical Association (17-09-2008)Get full text
Journal Article -
6
Perflubron emulsion delays blood transfusions in orthopedic surgery
Published in Anesthesiology (Philadelphia) (01-11-1999)Get full text
Journal Article -
7
Causes of metabolic acidosis in canine hemorrhagic shock: role of unmeasured ions
Published in Critical care (London, England) (01-01-2007)“…Metabolic acidosis during hemorrhagic shock is common and conventionally considered to be due to hyperlactatemia. There is increasing awareness, however, that…”
Get full text
Journal Article -
8
Randomized Safety Studies of Intravenous Perflubron Emulsion. I. Effects on Coagulation Function in Healthy Volunteers
Published in Anesthesia and analgesia (01-10-2000)“…Previous perfluorocarbon (PFC) emulsions have been associated with transient adverse events (i.e., platelet activation, decreased platelet count, febrile…”
Get full text
Journal Article -
9
Randomized Safety Studies of Intravenous Perflubron Emulsion. II. Effects on Immune Function in Healthy Volunteers
Published in Anesthesia and analgesia (01-10-2000)“…Particle size distribution is a major determinant of particle clearance by the mononuclear phagocytic system and the potential for concomitant activation of…”
Get full text
Journal Article -
10
Oxygen therapeutics ("blood substitutes") where are they, and what can we expect?
Published in Advances in experimental medicine and biology (2003)Get more information
Journal Article -
11
Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests
Published in Clinical chemistry (Baltimore, Md.) (01-09-1997)“…Polymerized hemoglobin solutions (Hb-based oxygen carriers; HBOCs) and a second-generation perfluorocarbon (PFC) emulsion (Perflubron) are in clinical trials…”
Get full text
Journal Article Conference Proceeding -
12
Perflubron emulsion (AF0144) augments harvesting of autologous blood: A phase II study in cardiac surgery
Published in Journal of cardiothoracic and vascular anesthesia (01-10-2002)“…Objective: To assess tolerance and preliminary efficacy of a perfluorocarbon emulsion (AF0144) used with acute normovolemic hemodilution to reduce allogeneic…”
Get full text
Journal Article -
13
Hemodilution and hyperoxia locally change distribution of regional pulmonary perfusion in dogs
Published in The American journal of physiology (01-02-1998)“…In seven anesthetized dogs, the effects of acute normovolemic hemodilution (ANH) to a hematocrit of 20 and 8% and the effects of hyperoxic ventilation (100%…”
Get full text
Journal Article -
14
Safety and Tolerability Of MP4CO: A Dose Escalation Study In Stable Patients With Sickle Cell Disease
Published in Blood (15-11-2013)“…▪ Vaso-occlusive crises (VOC) remain the hallmark of Sickle Cell Disease (SCD) yet to date no agent has been approved to hasten the resolution of an acute…”
Get full text
Journal Article -
15
Evaluation of MP4OX for Prevention of Perioperative Hypotension in Patients Undergoing Primary Hip Arthroplasty with Spinal Anesthesia
Published in Anesthesiology (Philadelphia) (01-05-2011)Get full text
Journal Article -
16
Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
Published in JAMA : the journal of the American Medical Association (17-09-2008)Get full text
Journal Article -
17
-
18
Oxygent as a top load to colloid and hyperoxia is more effective in resuscitation from hemorrhagic shock than colloid and hyperoxia alone
Published in Shock (Augusta, Ga.) (01-09-2005)“…Perfluorocarbon (PFC) emulsions are intravascular oxygen therapeutics that temporarily enhance tissue oxygenation in dilutional anemia. However, PFC emulsions…”
Get full text
Journal Article -
19
-
20
A Pilot Study of the Effects of a Perflubron Emulsion, AF 0104, on Mixed Venous Oxygen Tension in Anesthetized Surgical Patients
Published in Anesthesia and analgesia (01-01-1996)“…A pilot study of a perfluorochemical (PFC) emulsion was undertaken to determine whether administration of a perflubron emulsion could result in measurable…”
Get full text
Journal Article